Skip to main content

Table 2 Changes after treatment between two groups of patients with lesions

From: Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer

Group

Narrow OR stable lesions

Lesions increase

All cases

Apatinib group (n)

24

12

36

Control group (n)

32

40

72

P

  

0.029